[{"AccountsPayableCurrent_0_Q1_USD":7665000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":153735000.0,"SellingAndMarketingExpense_1_Q1_USD":17584000.0,"RepaymentsOfLongTermDebt_1_Q1_USD":0.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":2085000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-11716000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1972000.0,"OperatingLeaseExpense_1_Q1_USD":474000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-11716000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":7497000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":488773000.0,"OtherAssetsNoncurrent_0_Q1_USD":1302000.0,"LongTermDebtNoncurrent_0_Q1_USD":748000.0,"Goodwill_0_Q1_USD":2725000.0,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":5604000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":-484000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":5988461.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":539000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":63744000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":2582000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":9300887.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":2304000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-6185000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":603000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":2304000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":8576000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":11132000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1450000.0,"OperatingLeaseLiability_0_Q1_USD":12582000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":3435000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1760000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":2472000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":2543000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":2614000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":4227000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":16017000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":-135000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":0.0,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":2401000.0,"IncreaseDecreaseInInventories_1_Q1_USD":376000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":1275000.0,"ShareBasedCompensation_1_Q1_USD":2905000.0,"LiabilitiesCurrent_0_Q1_USD":19194000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":267100000.0,"Liabilities_0_Q1_USD":36678000.0,"InventoryNet_0_Q1_USD":6094000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":818000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-238000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":5450000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":7813000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-219000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.24,"CommonStockValue_0_Q1_USD":50000.0,"CommonStockSharesOutstanding_0_Q1_shares":49999923.0,"CommonStockSharesIssued_0_Q1_shares":49999923.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":153132000.0,"AssetsCurrent_0_Q1_USD":181362000.0,"Assets_0_Q1_USD":267100000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":5716509.0,"AccountsReceivableNetCurrent_0_Q1_USD":19091000.0,"CostsAndExpenses_1_Q1_USD":43322000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-665000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-5301000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":665000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":4407000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-12200000.0,"InterestPaidNet_1_Q1_USD":1000.0,"InterestExpense_1_Q1_USD":55000.0,"CommonStockSharesAuthorized_0_Q1_shares":125000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":10079000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":49792631.0,"StockholdersEquity_0_Q1_USD":230422000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-258401000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":8788000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3045000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":31122000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":1101000.0,"Ticker":"VCYT","CIK":"1384101","name":"VERACYTE, INC.","OfficialName":"Veracyte Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1700692789.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200506"}]